Pulmonary Arterial Hypertension (PAH): Understanding PAH & Abstracts | |
---|---|
Pulmonary Hypertension Abstracts | |
13:30 - 13:40 | O1287 - A Reversible and Irreversible Response to Haemodynamic Unloading in Flow-Induced Pulmonary Arterial Hypertension. - Identification of the Point of No Return in Pulmonary Vascular Disease Diederik van der Feen, Netherlands |
13:40 – 13:50 | O1308 - Macitentan Versus Standard of Care in Delaying Disease Progression in Children with Pulmonary Arterial Hypertension: The Tomorrow Study Design Maurice Beghetti, Switzerland |
13:50 – 14:00 | O1841 - Effect of Mir-29b on the Proliferation and Apoptosis of Pulmonary Artery Smooth Muscle Cells by Targeting CCND2 and Mcl-1 Juan Chen, China |
14:00 - 14:10 | O2039 - Potts Shunt Results Improves Right Ventricular Function in Patients with Suprasystemic Pulmonary Hypertension Manish Aggarwal, US |
14:10 - 14:20 | O2622 - Early Results and Long-Term Follow-Up: Double Patch Flap Valve VSD Closure in Patients with Pulmonary Hypertension and Elevated Pulmonary Vascular Resistance William Novick, US |
14:20 - 14:30 | O2778 - Right Atrial Function in Children with Pulmonary Hypertension Karun Vadlamudi, Canada |
14:30 - 14:42 | Epidemiology and Classification of Pulmonary Hypertension Rolf Berger, Netherlands |
14:42 – 14:54 | Imaging in Pulmonary Hypertension: Is it All About That RV? Mark Friedberg, Canada |
14:54 – 15:06 | Advanced imaging: Modalities: What Can They Add? Shahin Moledina, UK |
15:06 – 15:18 | Diagnostic Catheterization in Patients with PAH Christian Apitz, Germany |
15:18 – 15:30 | Pulmonary Hypertension in BPD Maria J. Del Cerro Marin, Spain |